Clinical trials
Hemophilia A trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 3 |
| 2010 | 5 |
| 2011 | 2 |
| 2012 | 5 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Recruiting | 6 |
| Active, not recruiting | 6 |
| Unknown status | 1 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 11 |
| Pfizer | 6 |
| Hoffmann-La Roche | 5 |
| BioMarin Pharmaceutical | 4 |
| Bioverativ, a Sanofi company | 3 |
| Baxalta now part of Shire | 2 |
| Bayer | 2 |
| Bioverativ Therapeutics Inc. | 2 |
| The Hospital for Sick Children | 2 |
| University of Sao Paulo General Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemophilia A | 44 |
| Hemophilia B | 11 |
| Hematologic Diseases | 5 |
| Blood Coagulation Disorders | 4 |
| Blood Coagulation Disorders, Inherited | 4 |
| Coagulation Protein Disorders | 4 |
| Genetic Diseases, Inborn | 4 |
| Hemorrhagic Disorders | 4 |
| Hemostatic Disorders | 4 |
| Hemarthrosis | 2 |
Trials
Showing 26 to 44 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.